(OPTZ) Optimize Strategy Index - Ratings and Ratios
Exchange: NASDAQ • Country: USA • Currency: USD • Type: Etf • • Mid-Cap Blend
OPTZ: Medium-Sized Companies, Balanced Investment Approach
Ticker Symbol: OPTZ | Exchange: NASDAQ | Type: ETF | Country Origin: USA | ETF Category: Mid-Cap Blend
The Optimize Strategy Index ETF (OPTZ) is a mid-cap blend ETF focused on U.S. equities. It seeks to provide exposure to mid-sized companies, blending both growth and value characteristics. The fund is designed to track the performance of its underlying index, which is optimized for specific investment criteria. Mid-cap blend ETFs typically invest in companies with market capitalizations between $2 billion and $10 billion, offering a balance between growth potential and stability compared to small- or large-cap equities.
Technical Data: Average Volume 20d: 4,000 shares | Last Price: $26.94 | SMA 20: $27.61 | SMA 50: $29.14 | SMA 200: $28.60 | ATR: 0.42
The ETF is currently trading below its 20-day and 50-day moving averages, indicating recent downward momentum. The 200-day moving average of $28.60 suggests a longer-term downtrend. The Average True Range (ATR) of 0.42 reflects low volatility, while the 20-day average volume of 4,000 shares indicates limited trading activity. These metrics suggest the ETF is in a consolidative phase with minimal directional movement.
Fundamental Data: AUM: $158.10 million
With assets under management (AUM) of $158.10 million, the ETF is a moderate-sized fund within its category. This level of AUM allows for efficient portfolio management while maintaining liquidity, though it may limit its ability to capitalize on smaller or more niche opportunities within the mid-cap space.
3-Month Forecast:
Technical Data: The ETF is likely to face resistance at its 50-day SMA ($29.14) and 200-day SMA ($28.60). Support levels may emerge near its recent lows, but the low ATR suggests limited upside potential. Expect a sideways to slightly bearish trend in the near term.
Fundamental Data: Mid-cap equities are sensitive to broader market conditions. If interest rates stabilize and economic growth shows signs of resilience, the ETF may experience modest inflows. However, with moderate AUM, it may lag larger, more liquid mid-cap ETFs in terms of performance.
Additional Sources for OPTZ ETF
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
OPTZ ETF Overview
Market Cap in USD | 143m |
Category | Mid-Cap Blend |
IPO / Inception | 2024-04-22 |
OPTZ ETF Ratings
Growth Rating | 12.3 |
Fundamental | - |
Dividend Rating | 1.51 |
Rel. Strength | -4.99 |
Analysts | - |
Fair Price Momentum | 20.78 USD |
Fair Price DCF | - |
OPTZ Dividends
Dividend Yield 12m | 0.36% |
Yield on Cost 5y | 0.38% |
Annual Growth 5y | -100.00% |
Payout Consistency | 100.0% |
OPTZ Growth Ratios
Growth Correlation 3m | -91.1% |
Growth Correlation 12m | 51.7% |
Growth Correlation 5y | 51.7% |
CAGR 5y | -0.13% |
CAGR/Max DD 5y | -0.01 |
Sharpe Ratio 12m | 1.01 |
Alpha | -7.22 |
Beta | 1.144 |
Volatility | 44.48% |
Current Volume | 0.5k |
Average Volume 20d | 4.9k |
As of April 18, 2025, the stock is trading at USD 25.23 with a total of 465 shares traded.
Over the past week, the price has changed by +1.15%, over one month by -9.31%, over three months by -16.62% and over the past year by -0.13%.
Neither. Based on ValueRay Analyses, Optimize Strategy Index is currently (April 2025) neither a good nor a bad stock to buy. It has a ValueRay Growth Rating of 12.27 and therefor a technical neutral rating according to historical growth.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of OPTZ as of April 2025 is 20.78. This means that OPTZ is currently overvalued and has a potential downside of -17.64%.
Optimize Strategy Index has no consensus analysts rating.
According to ValueRays Forecast Model, OPTZ Optimize Strategy Index will be worth about 23.2 in April 2026. The stock is currently trading at 25.23. This means that the stock has a potential downside of -8.13%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | - | - |
Analysts Target Price | - | - |
ValueRay Target Price | 23.2 | -8.1% |